We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-12.95%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$51.8B
AUM Growth
-$9.63B
Cap. Flow
-$699M
Cap. Flow %
-1.35%
Top 10 Hldgs %
15.72%
Holding
2,464
New
302
Increased
769
Reduced
979
Closed
219

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$792M
2
CA
CA, Inc.
CA
+$718M
3
V icon
Visa
V
+$129M
4
MA icon
Mastercard
MA
+$103M
5
EA icon
Electronic Arts
EA
+$98.7M

Sector Composition

Rank Sector Weight
1 Healthcare 18.67%
2 Financials 15.84%
3 Technology 11.21%
4 Industrials 8.66%
5 Energy 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LPX icon
301
Louisiana-Pacific
LPX
$5.2B
$34M 0.07%
1,528,283
+438,096
+40% +$9.93M
FBNC icon
302
First Bancorp
FBNC
$2.6B
$33.9M 0.07%
1,036,529
+152,422
+17% +$5.69M
TSEM icon
303
Tower Semiconductor
TSEM
$26.4B
$33.7M 0.07%
2,289,335
+28,200
+1% +$470K
EQC
304
DELISTED
Equity Commonwealth
EQC
$33.4M 0.06%
1,112,437
+137,253
+14% +$4.18M
LM
305
DELISTED
Legg Mason, Inc.
LM
$33.1M 0.06%
1,296,646
+26,600
+2% +$745K
AMX icon
306
America Movil
AMX
$78.1B
$32.9M 0.06%
2,307,878
+6,200
+0.3% +$89.1K
BDC icon
307
Belden
BDC
$4B
$32.9M 0.06%
786,529
-24,967
-3% -$1.36M
PFPT
308
DELISTED
Proofpoint, Inc.
PFPT
$32.7M 0.06%
390,403
-298,013
-43% -$27.6M
DOC
309
DELISTED
PHYSICIANS REALTY TRUST
DOC
$32.7M 0.06%
2,037,870
+347,137
+21% +$5.82M
EQIX icon
310
Equinix
EQIX
$107B
$32.7M 0.06%
92,646
-159,702
-63% -$62.2M
PG icon
311
Procter & Gamble
PG
$343B
$32.6M 0.06%
354,705
-2,821
-0.8% -$252K
LULU icon
312
lululemon athletica
LULU
$13B
$32.5M 0.06%
266,949
+32,295
+14% +$4.33M
MAIN icon
313
Main Street Capital
MAIN
$4.97B
$32.4M 0.06%
958,655
BAC icon
314
Bank of America
BAC
$435B
$32.3M 0.06%
1,312,733
-66,294
-5% -$1.8M
CVX icon
315
Chevron
CVX
$388B
$32.1M 0.06%
295,069
-62,270
-17% -$7.21M
KNL
316
DELISTED
Knoll, Inc.
KNL
$31.8M 0.06%
1,929,234
+16,355
+0.9% +$320K
UNP icon
317
Union Pacific
UNP
$183B
$31.5M 0.06%
228,077
-7,716
-3% -$1.14M
REGN icon
318
Regeneron Pharmaceuticals
REGN
$68.8B
$31.5M 0.06%
84,360
+14,030
+20% +$5.14M
BCPC
319
Balchem Corp
BCPC
$5.23B
$31.2M 0.06%
398,513
+13,444
+3% +$1.21M
VISN
320
Vistance Networks Inc
VISN
$2.66B
$31.2M 0.06%
1,904,660
-268,342
-12% -$5.69M
BOH icon
321
Bank of Hawaii
BOH
$3.33B
$31.1M 0.06%
461,776
-200,957
-30% -$15.3M
CUZ icon
322
Cousins Properties
CUZ
$5.29B
$30.7M 0.06%
971,406
+127,190
+15% +$4.24M
CRESY
323
Cresud
CRESY
$794M
$30.5M 0.06%
2,685,607
-4,302
-0.2% -$47.6K
AIMC
324
DELISTED
Altra Industrial Motion Corp
AIMC
$30.5M 0.06%
1,210,945
+12,541
+1% +$407K
SMG icon
325
ScottsMiracle-Gro
SMG
$4.03B
$30.4M 0.06%
494,075
+4,146
+0.8% +$295K

Similar funds

Macquarie Group's Q4 2018 Portfolio in Review

As of Q4 2018, Macquarie Group held 2,464 positions worth $51.8B, down 16% from $61.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Macquarie Group's Q4 2018 filing shows 302 new, 769 increased, 979 reduced and 219 closed positions. Its largest new stake was Rapid7: 873,643 shares worth $27.2M. The largest sale was Express Scripts Holding Company, an estimated $792M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q4 2018 buy was Rapid7: 873,643 shares worth $27.2M.
  • Macquarie Group added most to Cigna in Q4 2018, an estimated $723M increase.
  • Macquarie Group's biggest Q4 2018 reduction was Visa, cutting an estimated $129M.
  • Macquarie Group fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $792M.
  • Macquarie Group's ten largest holdings make up 16% of its $51.8B portfolio in Q4 2018.
  • Macquarie Group opened 302 new positions and closed 219 in Q4 2018.
  • Macquarie Group's portfolio value fell 16% quarter-over-quarter to $51.8B.

Based on Macquarie Group's 13F filing for Q4 2018, filed 15 Feb 2019.